Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: Imply the possible treatment of adenomyosis.

Journal of pharmacological sciences - 1 May 2018

Liu Li, Luo Ning, Guo Jing, Xie Yan, Chen Li, Cheng Zhongping

Abstract excerpt

Adenomyosis is a common chronic gynecological disorder with some tumor-like properties, including aberrant proliferation, invasion and migration. Berberine (BBR) is an isoquinoline derivative alkaloid with diverse pharmacological activities for the treatment of a wide variety of diseases. However, the effect of BBR on adenomyosis has not been understood. This study was to evaluate the potential therapeutic effect...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrium
Share to Epidermal Growth Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-8

Share to NF-kappa B

Share to STAT3 Transcription Factor

Share to Stromal Cells

Share to Transforming Growth Factor beta

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 29752208
DOI: 10.1016/j.jphs.2017.12.001

Genes

EGF
MMP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: Imply the possible treatment of adenomyosis.PMID 29752208Read ↗

Molecular mechanisms underlying the inhibition of cell migration and invasion in endometriosis: Advances in pharmacological research (Review)Semantic proximity Read ↗

Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to TherapiesSemantic proximity Read ↗

The anti-inflammatory mechanism of berberine on lipopolysaccharide-induced IEC-18 models based on comparative transcriptomicsSemantic proximity Read ↗

Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiologySemantic proximity Read ↗

Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1Semantic proximity Read ↗

Recent advances in understanding and managing adenomyosisSemantic proximity Read ↗

Oestrogen promotes the progression of adenomyosis by inhibiting CITED2 through miR-145Semantic proximity Read ↗

Alpha-boswellic acid accelerates acute wound healing via NF-κB signaling pathwaySemantic proximity Read ↗

Expression of high-mobility group box-1 in eutopic/ectopic endometrium and correlations with inflammation-related factors in adenomyosisSemantic proximity Read ↗

Exosomal miR-92a-3p serves as a promising marker and potential therapeutic target for adenomyosisSemantic proximity Read ↗

Harmine suppresses the proliferation and migration of human ovarian cancer cells through inhibiting ERK/CREB pathwaySemantic proximity Read ↗

Histopathological Association Between Chronic Endometritis and Adenomyosis: Clinical Findings and Risk FactorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.